Press Releases June 5, 2026 08:44 AM

Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference

Prestige Consumer Healthcare to Present at 2026 Oppenheimer Annual Consumer Growth and E-Commerce Conference

By Leila Farooq PBH

Prestige Consumer Healthcare Inc. announced its participation in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 8, 2026. The event will be available via live webcast and will cover the Company's market presence and product portfolio.

Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference
PBH

Key Points

  • Prestige Consumer Healthcare will present at a major industry conference focusing on consumer growth and e-commerce.
  • The company operates internationally with a diverse portfolio of healthcare products across several categories including women's health, pain relief, and oral care.
  • The webcast and replay options provide investors and stakeholders direct access to company insights and strategy discussions.

TARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference virtually on Monday, June 8, 2026 at 9:45 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:

https://ir.prestigebrands.com/events-presentations/events

For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.


Risks

  • Market reception to conference participation may be limited, resulting in minimal stock impact.
  • Competitive pressures in the consumer healthcare sector may challenge growth prospects highlighted.
  • Uncertainty in consumer demand trends and international market dynamics could affect future performance.

More from Press Releases

Genco Shipping & Trading Limited Highlights Recommendations from Leading Independent Proxy Advisory Firms Glass Lewis and Egan-Jones that Shareholders Vote “FOR” ALL of Genco’s Director Nominees Jun 5, 2026 SurgePays Signs Master Services Agreement with BrandRap to Build Artificial Intelligence (AI) Decisioning Engine to Drive Higher Revenue Per Subscriber Jun 5, 2026 SEGG Media Opens Exclusive First Access to Sports.com Predict Jun 5, 2026 Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories Jun 5, 2026 Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury Jun 5, 2026